Phase 3 Hepatic Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Chronic Hepatitis B With Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd.300 enrolled1 locationNCT07343778
Recruiting
Phase 2Phase 3
HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
Solid Tumor, AdultAdvanced Intrahepatic Cholangiocarcinoma
Hutchmed235 enrolled1 locationNCT04353375
Recruiting
Phase 3
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
NAFLDHepatic SteatosisAdolescent Obesity
University of Colorado, Denver55 enrolled1 locationNCT05935826
Recruiting
Phase 3
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd.480 enrolled1 locationNCT05342194
Recruiting
Phase 3
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
Hepatic Encephalopathy
Tanta University60 enrolled1 locationNCT04161053
Completed
Phase 3
Oral Supplementation with Taurine for Patients with Cirrhosis and Muscle Cramps
Hepatic CirrhosisMuscle Cramps
Royal Prince Alfred Hospital50 enrolled1 locationACTRN12612000289819